Quotes 5-day view End-of-day quote Tokyo Stock Exchange
11/26/2020
11/27/2020
11/30/2020
12/01/2020
12/02/2020
Date
1388
1386
1323
1314
1310
Last
1108500
878300
1449400
885500
1061700
Volume
+2.06% -0.14% -4.55% -0.68% -0.30% Change
Sales 2021
507 B 4 869 M 4 869 M
Net income 2021
21 341 M 205 M 205 M
Net Debt 2021
167 B 1 609 M 1 609 M
P/E ratio 2021
20,2x
Yield 2021
2,14%
Sales 2022
514 B 4 934 M 4 934 M
Net income 2022
29 727 M 286 M 286 M
Net Debt 2022
174 B 1 672 M 1 672 M
P/E ratio 2022
16,2x
Yield 2022
2,15%
Capitalization
526 B 5 031 M 5 053 M
EV / Sales 2021
1,37x
EV / Sales 2022
1,36x
Nbr of Employees
6 457
Free-Float
40,6%
Sumitomo Dainippon Pharma Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (92.3%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.7%): veterinary drugs, food additives, industrial chemical products,...
Notations Surperformance© of Sumitomo Dainippon Pharma Co., Ltd.
Trading Rating : Investor Rating :
All news about SUMITOMO DAINIPPON PHARMA CO., LTD.
News in other languages on SUMITOMO DAINIPPON PHARMA CO., LTD.
Chart SUMITOMO DAINIPPON PHARMA CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SUMITOMO DAINIPPON PHARMA CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
UNDERPERFORM
Number of Analysts
9
Average target price
1 370,00 JPY
Last Close Price
1 310,00 JPY
Spread / Highest target
52,7%
Spread / Average Target
4,58%
Spread / Lowest Target
-16,0%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
